WuXi AppTec Co., Ltd. (BKK:WUXIAT80)

Market Cap	1.25T
Revenue (ttm)	200.16B
Net Income (ttm)	68.39B
Shares Out	n/a
EPS (ttm)	21.23
PE Ratio	18.31
Forward PE	18.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,869
Average Volume	118,505
Open	4.400
Previous Close	4.380
Day's Range	4.360 - 4.420
52-Week Range	4.220 - 4.420
Beta	n/a
RSI	n/a
Earnings Date	Mar 15, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula...

• Industry: Commercial Physical and Biological Research
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: WUXIAT80

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY